Is cABYR a novel cancer-testis antigen in lung cancer?
CABYR is a novel CT antigen in lung cancer and may be a promising target for immunotherapy for lung cancer patients.
We concluded that addition of clonidine to bupivacaine prolongs the duration of post-operative analgesia without any respiratory or hemodynamic side-effects.